Up to 750,000 unused testing kits to be recalled
News
Destiny Pharma’s novel antibiotic asset clears safety review
Independent Data Monitoring Committee recommended continuing Phase IIb study
Eli Lilly, Pieris collaborate on HER2-positive cancer clinical programme
Companies will focus on HER2-positive gastric cancer
Roche’s SMA treatment Evrysdi bags US approval
Drug cleared for use in SMA patients aged two months or older
Pfizer inks manufacturing deal with Gilead for COVID-19 med remdesivir
Pfizer becomes one of multiple external manufacturing organisations supporting scale-up of treatment
Opdivo/Yervoy improves survival in pleural mesothelioma
Combination therapy showed benefit in hard-to-treat cancer type
UK government announces funding boost for nursing apprenticeships
New government package will be worth £172m
Roche post mixed results for etrolizumab in ulcerative colitis
Phase III study of drug in Crohn’s disease is ongoing
EU approves new indication for Novartis’ Xolair
Allergy drug approved for severe chronic rhinosinusitis with nasal polyps
Researchers say hydroxychloroquine could still prevent COVID-19
Scientists from the University of Oxford say the drug is being ‘discarded prematurely’
GSK’s anti-BCMA drug Blenrep wins US approval
First anti-BCMA therapy to be approved anywhere in the world
Second COVID-19 peak in the UK can be avoided with testing and tracing, study finds
Study co-led by UCL and the London School of Hygiene & Tropical Medicine
AZ’s Fasenra study confirms robust efficacy in eosinophilic asthma
Drug reduced annual rate of asthma exacerbations by 49%
UCB’s Cimzia bags EU label extension
Drug is first biologic in Europe to be approved with a dose reduction label for axSpA patients
NICE updates guidance on chronic pain treatments
Draft guidance says some commonly used drug treatments should be avoided
